Annual Net Income
-$39.14 M
-$6.60 M-20.27%
September 30, 2024
Summary
- As of February 21, 2025, CTXR annual net profit is -$39.14 million, with the most recent change of -$6.60 million (-20.27%) on September 30, 2024.
- During the last 3 years, CTXR annual net income has fallen by -$16.08 million (-69.77%).
- CTXR annual net income is now -177803.64% below its all-time high of -$22.00 thousand, reached on September 30, 2012.
Performance
CTXR Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$9.77 M
+$1.02 M+9.47%
December 1, 2024
Summary
- As of February 21, 2025, CTXR quarterly net profit is -$9.77 million, with the most recent change of +$1.02 million (+9.47%) on December 1, 2024.
- Over the past year, CTXR quarterly net income has increased by +$805.10 thousand (+7.61%).
- CTXR quarterly net income is now -697628.57% below its all-time high of -$1400.00, reached on December 31, 2012.
Performance
CTXR Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$39.68 M
-$537.00 K-1.37%
December 1, 2024
Summary
- As of February 21, 2025, CTXR TTM net profit is -$39.68 million, with the most recent change of -$537.00 thousand (-1.37%) on December 1, 2024.
- Over the past year, CTXR TTM net income has dropped by -$1.38 million (-3.61%).
- CTXR TTM net income is now -440743.33% below its all-time high of -$9000.00, reached on December 31, 2010.
Performance
CTXR TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
CTXR Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.3% | +7.6% | -3.6% |
| 3 y3 years | -69.8% | +7.6% | -3.6% |
| 5 y5 years | -151.5% | +7.6% | -3.6% |
CTXR Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.8% | at low | -171.8% | +9.5% | -64.4% | at low |
| 5 y | 5-year | -151.5% | at low | -171.8% | +9.5% | -147.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +9.5% | <-9999.0% | at low |
Citius Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | -$9.77 M(-9.5%) | -$39.68 M(+1.4%) |
| Sep 2024 | -$39.14 M(+20.3%) | -$10.79 M(+2.1%) | -$39.14 M(+2.2%) |
| Jun 2024 | - | -$10.57 M(+23.7%) | -$38.29 M(+5.8%) |
| Mar 2024 | - | -$8.54 M(-7.4%) | -$36.20 M(-5.2%) |
| Dec 2023 | - | -$9.23 M(-7.2%) | -$38.18 M(+17.3%) |
| Sep 2023 | -$32.54 M(-3.3%) | -$9.94 M(+17.3%) | -$32.54 M(+6.4%) |
| Jun 2023 | - | -$8.48 M(-19.4%) | -$30.59 M(-1.2%) |
| Mar 2023 | - | -$10.53 M(+192.9%) | -$30.97 M(+10.6%) |
| Dec 2022 | - | -$3.59 M(-55.0%) | -$28.01 M(-16.7%) |
| Sep 2022 | - | -$7.99 M(-9.8%) | -$33.64 M(+9.9%) |
| Sep 2022 | -$33.64 M(+45.9%) | - | - |
| Jun 2022 | - | -$8.86 M(+17.2%) | -$30.61 M(+11.0%) |
| Mar 2022 | - | -$7.56 M(-18.0%) | -$27.57 M(+14.2%) |
| Dec 2021 | - | -$9.23 M(+86.0%) | -$24.13 M(+4.7%) |
| Sep 2021 | -$23.05 M(+31.4%) | -$4.96 M(-14.8%) | -$23.05 M(+3.8%) |
| Jun 2021 | - | -$5.82 M(+41.3%) | -$22.21 M(+5.4%) |
| Mar 2021 | - | -$4.12 M(-49.4%) | -$21.07 M(-1.4%) |
| Dec 2020 | - | -$8.15 M(+97.7%) | -$21.37 M(+21.8%) |
| Sep 2020 | -$17.55 M(+12.8%) | -$4.12 M(-12.0%) | -$17.55 M(+2.8%) |
| Jun 2020 | - | -$4.68 M(+5.8%) | -$17.08 M(+1.6%) |
| Mar 2020 | - | -$4.42 M(+2.4%) | -$16.80 M(+5.0%) |
| Dec 2019 | - | -$4.32 M(+18.4%) | -$16.01 M(+2.9%) |
| Sep 2019 | -$15.56 M(+24.1%) | -$3.65 M(-17.2%) | -$15.56 M(+5.4%) |
| Jun 2019 | - | -$4.41 M(+21.3%) | -$14.76 M(+19.3%) |
| Mar 2019 | - | -$3.63 M(-6.3%) | -$12.38 M(-6.0%) |
| Dec 2018 | - | -$3.87 M(+36.1%) | -$13.17 M(+5.0%) |
| Sep 2018 | -$12.54 M | -$2.85 M(+40.8%) | -$12.54 M(-1.5%) |
| Jun 2018 | - | -$2.02 M(-54.3%) | -$12.73 M(-3.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$4.42 M(+36.2%) | -$13.13 M(+14.6%) |
| Dec 2017 | - | -$3.25 M(+6.7%) | -$11.46 M(+10.3%) |
| Sep 2017 | -$10.38 M(+25.2%) | -$3.04 M(+25.6%) | -$10.38 M(+4.6%) |
| Jun 2017 | - | -$2.42 M(-11.7%) | -$9.93 M(-10.7%) |
| Mar 2017 | - | -$2.74 M(+26.1%) | -$11.12 M(+20.3%) |
| Dec 2016 | - | -$2.18 M(-16.0%) | -$9.25 M(+11.5%) |
| Sep 2016 | -$8.30 M(+185.8%) | -$2.59 M(-28.4%) | -$8.30 M(+25.4%) |
| Jun 2016 | - | -$3.62 M(+315.9%) | -$6.61 M(+73.0%) |
| Mar 2016 | - | -$869.50 K(-28.8%) | -$3.82 M(+15.9%) |
| Dec 2015 | - | -$1.22 M(+34.4%) | -$3.30 M(+13.7%) |
| Sep 2015 | -$2.90 M(+9143.0%) | -$908.30 K(+10.1%) | -$2.90 M(+45.6%) |
| Jun 2015 | - | -$825.00 K(+138.9%) | -$1.99 M(+65.6%) |
| Mar 2015 | - | -$345.30 K(-58.1%) | -$1.20 M(+26.9%) |
| Dec 2014 | - | -$823.70 K(+2260.2%) | -$948.90 K(+40.6%) |
| Jun 2014 | - | -$34.90 K(-61.4%) | -$674.90 K(+4.7%) |
| Mar 2014 | - | -$90.30 K(-83.1%) | -$644.40 K(+14.2%) |
| Dec 2013 | - | -$534.40 K(+3392.8%) | -$564.30 K(+1702.9%) |
| Sep 2013 | -$31.40 K(+42.7%) | -$15.30 K(+247.7%) | -$31.30 K(+46.3%) |
| Jun 2013 | - | -$4400.00(-56.9%) | -$21.40 K(-10.1%) |
| Mar 2013 | - | -$10.20 K(+628.6%) | -$23.80 K(+14.4%) |
| Dec 2012 | - | -$1400.00(-74.1%) | -$20.80 K(-5.5%) |
| Sep 2012 | -$22.00 K(-16.3%) | -$5400.00(-20.6%) | -$22.00 K(+13.4%) |
| Jun 2012 | - | -$6800.00(-5.6%) | -$19.40 K(-2.5%) |
| Mar 2012 | - | -$7200.00(+176.9%) | -$19.90 K(-0.5%) |
| Dec 2011 | - | -$2600.00(-7.1%) | -$20.00 K(-24.2%) |
| Sep 2011 | -$26.30 K | -$2800.00(-61.6%) | -$26.40 K(+11.9%) |
| Jun 2011 | - | -$7300.00(0.0%) | -$23.60 K(+44.8%) |
| Mar 2011 | - | -$7300.00(-18.9%) | -$16.30 K(+81.1%) |
| Dec 2010 | - | -$9000.00 | -$9000.00 |
FAQ
- What is Citius Pharmaceuticals annual net profit?
- What is the all time high annual net income for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual net income year-on-year change?
- What is Citius Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly net income year-on-year change?
- What is Citius Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals TTM net income year-on-year change?
What is Citius Pharmaceuticals annual net profit?
The current annual net income of CTXR is -$39.14 M
What is the all time high annual net income for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual net profit is -$22.00 K
What is Citius Pharmaceuticals annual net income year-on-year change?
Over the past year, CTXR annual net profit has changed by -$6.60 M (-20.27%)
What is Citius Pharmaceuticals quarterly net profit?
The current quarterly net income of CTXR is -$9.77 M
What is the all time high quarterly net income for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly net profit is -$1400.00
What is Citius Pharmaceuticals quarterly net income year-on-year change?
Over the past year, CTXR quarterly net profit has changed by +$805.10 K (+7.61%)
What is Citius Pharmaceuticals TTM net profit?
The current TTM net income of CTXR is -$39.68 M
What is the all time high TTM net income for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high TTM net profit is -$9000.00
What is Citius Pharmaceuticals TTM net income year-on-year change?
Over the past year, CTXR TTM net profit has changed by -$1.38 M (-3.61%)